Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May;64(5):978-984.
doi: 10.1007/s00125-020-05354-7. Epub 2021 Jan 16.

Minimising hypoglycaemia in the real world: the challenge of insulin

Affiliations
Review

Minimising hypoglycaemia in the real world: the challenge of insulin

Chantal Mathieu. Diabetologia. 2021 May.

Abstract

Insulin therapy has been a life saver for people with type 1 diabetes and has been an essential tool in the therapy of people with type 2 diabetes, but the risk for hypoglycaemia has been a major hurdle to achieving good glycaemic control for most. Insulin analogues, the availability of novel technologies for the administration of insulin, like insulin pumps, and, in particular, tools to measure glucose levels, evolving from capillary measurements to continuous glucose monitoring, have revolutionised the way in which people living with diabetes use insulin. Novel insulin concepts, like once-weekly or oral insulin administration, will have to demonstrate safety on the side of hypoglycaemia before they will be able to move into the clinic.

Keywords: Hypoglycaemia; Insulin; Insulin analogues; Real world; Review.

PubMed Disclaimer

References

    1. Atkinson MA, Eisenbarth GS, Michels AW (2014) Type 1 diabetes. Lancet 383:69–82. https://doi.org/10.1016/S0140-6736(13)60591-7 - DOI - PubMed
    1. Zaccardi F, Webb DR, Yates T, Davies MJ (2016) Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med J 92(1084):63–69. https://doi.org/10.1136/postgradmedj-2015-133281 - DOI - PubMed
    1. International Hypoglycaemia Study Group (2017) Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 60:3–6. https://doi.org/10.1007/s00125-016-4146-6 - DOI
    1. Battelino T, Danne T, Bergenstal RM et al (2019) Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 42(8):1593–1603. https://doi.org/10.2337/dci19-0028 - DOI - PubMed - PMC
    1. Charleer S, De Block C, Van Huffel L et al (2020) Quality of life and glucose control after 1 year of nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type 1 diabetes (FUTURE): a prospective observational real-world cohort study. Diabetes Care 43(2):389–397. https://doi.org/10.2337/dc19-1610 - DOI - PubMed

MeSH terms

LinkOut - more resources